All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Scorr-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Samsung Biologics

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Korea, Republic Of

Post An Enquiry

ISPE Manufacturing

Participation Not Confirmed

Update your events

Samsung Biologics expands presence in Greater China Region with CDO partnership for Alzheimer's candidate

Contact the Supplier

Lead Product(s): Anti-tau monoclonal antibody

Therapeutic Area: Neurology

Highest Development Status: Undisclosed Product Type: Large molecule

Partner/Sponsor/Collaborator: Aprinoia Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement March 16, 2020

Details:

The candidate was selected from APRINOIA’s proprietary antibody platform to target specific pathological tau aggregates with novel conformation-dependent epitopes.